Cargando…

Evaluation of vascular endothelial growth factor (VEGF) level in the tears and serum of age-related macular degeneration patients

Age-related macular degeneration (AMD) is an important cause of irreversible central blindness worldwide. Clinical manifestations range from asymptomatic in early and intermediate AMD to significant vision loss in late AMD. Approximately 10% of cases of early AMD eventually progress to the late adva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shahidatul-Adha, Mohamad, Zunaina, Embong, Aini-Amalina, Mazlan N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924159/ https://www.ncbi.nlm.nih.gov/pubmed/35292705 http://dx.doi.org/10.1038/s41598-022-08492-7

Ejemplares similares

Caecocentral Scotoma: A Rare Presentation of Optic Perineuritis
por: Mohamad, Shahidatul-Adha, et al.
Publicado: (2019)

Evaluation of vascular endothelial growth factor levels in tears and serum among diabetic patients
por: Ang, Wen Jeat, et al.
Publicado: (2019)

Intravitreal Anti-vascular Endothelial Growth Factor (Anti-VEGF) Therapy for Valsalva Related Sub-internal Limiting Membrane (Sub-ILM) Macular Haemorrhage: A Case Report
por: Nur-Najwa, Suhaifi, et al.
Publicado: (2023)

Ocular Sporotrichosis with Limbal Stem Cell Deficiency: An Impostor with Blinding Sequelae
por: Mohamad, Shahidatul-Adha, et al.
Publicado: (2023)

Pediatric Sinonasal Rhabdomyosarcoma Presented as Squint: A Case Report and Literature Review
por: Shahidatul-Adha, Mohamad, et al.
Publicado: (2021)

MicroRNA Profiling of the Tears of Children With Vernal Keratoconjunctivitis
por: Syed, Nazmul Huda, et al.
Publicado: (2022)

Correlation of retinal nerve fibre layer and macular thickness with serum uric acid among type 2 diabetes mellitus
por: Vinuthinee-Naidu, Munisamy-Naidu, et al.
Publicado: (2017)

Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema - a comparative pilot study
por: Norlaili, Mustapha, et al.
Publicado: (2011)

Ocular tuberculosis in Hospital Universiti Sains Malaysia – A case series
por: Shahidatul-Adha, M., et al.
Publicado: (2017)

Methodological Concerns Regarding Levels of Vascular Endothelial Growth Factor (VEGF) in Serum of Women with Endometriosis
por: Leone Roberti Maggiore, Umberto, et al.
Publicado: (2015)

Anti-vascular endothelial growth factor in neovascular age-related macular degeneration – a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems
por: Finger, Robert P., et al.
Publicado: (2020)

The correlation between serum vascular endothelial growth factor (VEGF) and tumor VEGF receptor 3 in colorectal cancer
por: Goulart, André, et al.
Publicado: (2019)

Omega-3 Supplementation Combined With Anti–Vascular Endothelial Growth Factor Lowers Vitreal Levels of Vascular Endothelial Growth Factor in Wet Age-Related Macular Degeneration
por: REZENDE, FLAVIO A., et al.
Publicado: (2014)

Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancer.
por: Obermair, A., et al.
Publicado: (1998)

Tear film proteome in age-related macular degeneration
por: Winiarczyk, Mateusz, et al.
Publicado: (2018)

Impact of Delayed Intravitreal Anti-Vascular Endothelial Growth Factor (VEGF) Therapy Due to the Coronavirus Disease Pandemic on the Prognosis of Patients with Neovascular Age-Related Macular Degeneration
por: Kim, Jae-Gon, et al.
Publicado: (2022)

Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels.
por: Yamamoto, S., et al.
Publicado: (1997)

Macular Atrophy Development and Subretinal Drusenoid Deposits in Anti-Vascular Endothelial Growth Factor Treated Age-Related Macular Degeneration
por: Zarubina, Anna V., et al.
Publicado: (2017)

The economic implications of the use of anti-vascular endothelial growth factor drugs in age-related macular degeneration
por: Azad, Rajvardhan, et al.
Publicado: (2007)

Anti-vascular endothelial growth factor in age-related macular degeneration: Puzzle or a silent beginning!
por: Natarajan, Sundaram
Publicado: (2013)

Vascular endothelial growth factor genetic polymorphisms and susceptibility to age-related macular degeneration in Tunisian population
por: Habibi, Imen, et al.
Publicado: (2014)

Vascular endothelial growth factor genetic polymorphisms and susceptibility to age-related macular degeneration in Tunisian population
por: Habibi, Imen, et al.
Publicado: (2012)

Vascular endothelial growth factor gene polymorphisms and association with age related macular degeneration in Indian patients
por: Gupta, Divya, et al.
Publicado: (2016)

Vascular Endothelial Growth Factor Antagonists: Promising Players in the Treatment of Neovascular Age-Related Macular Degeneration
por: Hussain, Rehan M, et al.
Publicado: (2021)

Intravitreal anti-vascular endothelial growth factor monotherapy in age-related macular degeneration with submacular hemorrhage
por: Maruyama-Inoue, Maiko, et al.
Publicado: (2023)

Melatonin Inhibits VEGF-Induced Endothelial Progenitor Cell Angiogenesis in Neovascular Age-Related Macular Degeneration
por: Lin, Liang-Wei, et al.
Publicado: (2023)

The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy
por: Pożarowska, Dorota, et al.
Publicado: (2016)

Patient Preferences Associated with Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
por: Bhagat, Davis, et al.
Publicado: (2020)

The importance of serum and pleural fluid level of vascular endothelial growth factor (VEGF) and VEGF fluid/serum ratio in the differential diagnosis of malignant mesothelioma-related pleural effusion
por: Düzköprü, Yakup, et al.
Publicado: (2017)

Commentary
por: Zunaina, Embong
Publicado: (2012)

Exploring the role of VEGF in Indian Age related macular degeneration
por: Sharma, Kaushal, et al.
Publicado: (2015)

Introduction, mechanism of action and rationale for anti-vascular endothelial growth factor drugs in age-related macular degeneration
por: Kim, Ramasamy
Publicado: (2007)

Association between Vascular Endothelial Growth Factor Polymorphisms and Age-Related Macular Degeneration: An Updated Meta-Analysis
por: Barchitta, Martina, et al.
Publicado: (2016)

Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration
por: Wingard, Jeremy B, et al.
Publicado: (2019)

Ten-year outcome of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration
por: Upasani, Deepa, et al.
Publicado: (2021)

Effects of delay in anti-vascular endothelial growth factor intravitreal injections for neovascular age-related macular degeneration
por: Hanhart, Joel, et al.
Publicado: (2022)

Twenty Years of Anti-Vascular Endothelial Growth Factor Therapeutics in Neovascular Age-Related Macular Degeneration Treatment
por: Moon, Bo-Hyun, et al.
Publicado: (2023)

Choroidal neovascularization secondary to Best’s vitelliform macular dystrophy in two siblings of a Malay family
por: Alisa-Victoria, Koh, et al.
Publicado: (2014)

Expression of vascular endothelial growth factor (VEGF) in equine sarcoid
por: Martano, Manuela, et al.
Publicado: (2018)

VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease
por: Barratt, Shaney L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fb0ir66vcn0oqf2u7iqg5vb7td